FDA Studies Foreshadow Potential Changes to Direct-to-Consumer Prescription Drug Advertising

The Food and Drug Administration (FDA) recently conducted two online studies concerning comprehension of direct-to-consumer (DTC) prescription oncology drug advertising.  The research suggests that consumers may have difficulty understanding the consequences of various drug study endpoints, resulting in consumers’ overly optimistic views of study results and oncology drug efficacy….
By: Nelson Mullins Riley & Scarborough LLP